Additional clinical support showed reduction of MBNL1-AS1 in NSCLC tissue of patients with lymph node metastasis vs. normal adjacent tissue and NSCLC tissue from patients without lymph node metastasis. This evidence concerns the gene MBNL1 and non-small cell lung carcinoma.